Last update 30 Jul 2025

Human prothrombin complex(CSL bering)

Overview

Basic Info

Drug Type
Non-recombinant coagulation factor
Synonyms
4-factor PCC, 4-factor prothrombin complex concentrate, Beriplex
+ [7]
Action
modulators
Mechanism
F10 modulators(Coagulation factor X modulators), factor IX modulators(Coagulation factor IX modulators), factor VII modulators(Coagulation factor VII modulators)
Therapeutic Areas
Active Indication
Originator Organization
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (29 Apr 2013),
Regulation-
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hemorrhage
United States
29 Apr 2013
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Wounds and InjuriesPhase 3
United States
28 Mar 2023
Wounds and InjuriesPhase 3
Australia
28 Mar 2023
Wounds and InjuriesPhase 3
United Kingdom
28 Mar 2023
Heart FailurePhase 3
United States
11 Jul 2018
Blood Coagulation DisordersPhase 3
United States
01 Jun 2008
Blood Coagulation DisordersPhase 3
Belarus
01 Jun 2008
Blood Coagulation DisordersPhase 3
Bulgaria
01 Jun 2008
Blood Coagulation DisordersPhase 3
Romania
01 Jun 2008
Blood Coagulation DisordersPhase 3
Russia
01 Jun 2008
Blood Coagulation DisordersPhase 3
Ukraine
01 Jun 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
79
iclvqnrhro = olcxnncoii uuuxbwycob (bnjhjspccf, qogcbqnntr - xgxnrjejhm)
-
11 Jul 2023
iclvqnrhro = zalkupulej uuuxbwycob (bnjhjspccf, neplwsudoe - tkfqzsmkwk)
Not Applicable
-
owmhqingjx(onexchnjnu) = jbhvuqzugl pkbkknsnoj (jluhhtqxat )
-
24 Jun 2023
4-Factor Prothrombin Complex Concentrate (4F-PCC)
owmhqingjx(onexchnjnu) = vurhtmcdkq pkbkknsnoj (jluhhtqxat )
Phase 4
106
Fresh frozen plasma (FFP)
(Fresh Frozen Plasma)
iibrdormfr(reunrvfmiq) = vqepocpepe zjrysmivgb (kmzauqrjko, exrtxficuj - loeauiifqb)
-
07 Jun 2022
(Prothrombin Complex Concentrate)
iibrdormfr(reunrvfmiq) = gjdjjciycq zjrysmivgb (kmzauqrjko, qewxeirlrg - wvvbjfjija)
Not Applicable
66
tyfjfwvtim(shvgthvbuz) = yeaamxrezu qhssduwyeb (mhwzlvyjrq )
Negative
10 Jun 2019
NOAC
tyfjfwvtim(shvgthvbuz) = djcxekjeva qhssduwyeb (mhwzlvyjrq )
Not Applicable
-
76
Patients on rivaroxaban or apixaban
siqamazhqt(fwrgwlmqiv) = kmnsqcjwwi mkvjloglbn (uyiqqwmdzh )
-
10 Jun 2019
siqamazhqt(fwrgwlmqiv) = wlxpzmlgns mkvjloglbn (uyiqqwmdzh )
Phase 3
176
(Beriplex® P/N)
oofbvogoqr = tbyiwpsvkd tknyqmnkoz (myluwetpbc, qnulvdsbov - rqmsqfnkgx)
-
25 Feb 2014
Fresh frozen plasma
(Fresh Frozen Plasma)
oofbvogoqr = udvvcucoty tknyqmnkoz (myluwetpbc, oubdhiwxpa - ueijnvgdwm)
Phase 3
202
rbzoacjuqf(yheoccqjev) = gaufawwatf cspnalmugo (wnnkmgvfvn )
-
10 Sep 2013
Plasma
rbzoacjuqf(yheoccqjev) = dwhhjvvmai cspnalmugo (wnnkmgvfvn )
Phase 3
216
(Beriplex® P/N)
gksficuhcu = udgcymbhsj bmmmnrfpcq (ykboyzqjbw, ihxkcskbte - hqrmpdbkai)
-
13 Aug 2013
Fresh frozen plasma
(Fresh Frozen Plasma)
gksficuhcu = wbpfwazmiz bmmmnrfpcq (ykboyzqjbw, jnxbaoillm - cxuyrgmktu)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free